HCW Biologics Inc. Quarterly Liabilities, Current in USD from Q4 2020 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: HCW Biologics Inc. quarterly Liabilities, Current history and growth rate from Q4 2020 to Q2 2025.
HCW Biologics Inc. Liabilities, Current for the quarter ending June 30, 2025 was $26.8M, a 15.6% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$26.8M	+$3.63M	+15.6%	Jun 30, 2025	10-Q	2025-08-18
Q1 2025	$27.1M	+$13.7M	+102%	Mar 31, 2025	10-Q	2025-05-15
Q4 2024	$29.6M	+$20.9M	+239%	Dec 31, 2024	10-Q	2025-08-18
Q3 2024	$30.1M	+$24.6M	+455%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$23.2M	+$18.7M	+412%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$13.4M	+$8.89M	+197%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$8.75M	+$5.79M	+196%	Dec 31, 2023	10-K	2025-03-28
Q3 2023	$5.42M	+$3.12M	+136%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$4.54M	+$3.39M	+296%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$4.52M	+$3.1M	+219%	Mar 31, 2023	10-Q/A	2023-08-10
Q4 2022	$2.96M	+$635K	+27.3%	Dec 31, 2022	10-K/A	2024-05-15
Q3 2022	$2.29M	-$101K	-4.23%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$1.14M	-$3.02M	-72.5%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$1.42M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$2.32M	+$1.32M	+132%	Dec 31, 2021	10-K	2023-03-28
Q3 2021	$2.39M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$4.17M			Jun 30, 2021	10-Q	2021-08-13
Q4 2020	$1M			Dec 31, 2020	10-K	2022-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.